View of Designed 1-Hydroxynaphthalene-2-Carboxanilide Derivatives were evaluated for their Anticancer drug candidate properties by performing a Silico Pharmacokinetic and Silico Toxicological Analysis

Return to Article Details Designed 1-Hydroxynaphthalene-2-Carboxanilide Derivatives were evaluated for their Anticancer drug candidate properties by performing a Silico Pharmacokinetic and Silico Toxicological Analysis Download Download PDF